Stryker Corp (SYK)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$388.96

Buy

$389.59

arrow-up$1.3981 (+0.36%)

Prices updated at 13 May 2025, 17:51 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Stryker Corp is engaged in designing, manufacturing and marketing of medical equipment, instruments, and implantable devices. Its products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices.
S&P 500
arrow-up0.9%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Kevin A. Lobo
CEO
Mr. Kevin A. Lobo
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
53,000
Head office
1941 Stryker Way
Portage
United States
49002
mobile
+1 269 385-2600
letter
jason.beach@stryker.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Allan C. Golston
Independent Director
0.14m
Mr. Preston W. Wells
Vice President and Chief Financial Officer
-
Ms. Ronda E. Stryker
Independent Director
0.13m
Ms. Sherilyn S. McCoy
Lead Independent Director
0.17m
Ms. Mary K. Brainerd
Independent Director
0.14m
Mr. Andrew K. Silvernail
Independent Director
0.15m
Mr. Kevin A. Lobo
Chairman of the Board, Chief Executive Officer and President
1.44m
Dr. Giovanni Caforio, M.D.
Independent Director
0.13m
Mr. William E. Berry, Jr
Vice President, Corporate Controller and Chief Accounting Officer
-
Mr. Rajeev Suri
Independent Director
0.13m
Ms. Lisa M. Skeete Tatum
Independent Director
0.13m
Ms. Yin C. Becker
Vice President and Chief Corporate Affairs Officer
-
Ms. M. Kathryn Fink
Vice President and Chief Human Resources Officer
-
Mr. Viju S. Menon
Group President, Global Quality and Operations
0.65m
Mr. Spencer S. Stiles
Group President, Orthopaedics and Spine
0.75m
Mr. Robert S Fletcher
Vice President and Chief Legal Officer
-
Ms. Rachel M. Ruggeri
Independent Director
0.08m
Mr. J. Andrew Pierce
Group President, MedSurg and Neurotechnology
0.75m
Mr. Emmanuel P. Maceda
Independent Director
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Vanguard Group Inc32,698,828
BlackRock Inc26,810,080
Greenleaf Trust17,116,802
State Street Corp14,779,118
T. Rowe Price Associates, Inc.11,109,722

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
31 Dec 2024-
31 Dec 2024-
31 Dec 2024-
27 Dec 2024-
27 Dec 2024-
27 Dec 2024-
23 Dec 2024-
23 Dec 2024-
23 Dec 2024-
17 Dec 2024-
18 Nov 2024-
18 Nov 2024-
18 Nov 2024-
15 Nov 2024-
14 Nov 2024-
07 Nov 2024-
07 Nov 2024-
07 Nov 2024-
07 Nov 2024-
07 Nov 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.